| scholarly article | Q13442814 |
| P356 | DOI | 10.1289/EHP.9298107 |
| P953 | full work available at URL | https://europepmc.org/articles/PMC1519624 |
| https://europepmc.org/articles/PMC1519624?pdf=render | ||
| P932 | PMC publication ID | 1519624 |
| P698 | PubMed publication ID | 1486838 |
| P5875 | ResearchGate publication ID | 21668559 |
| P2093 | author name string | N. K. Spurr | |
| C. A. Smith | |||
| C. R. Wolf | |||
| A. C. Gough | |||
| J. E. Moss | |||
| P2860 | cites work | Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase | Q26778389 |
| 15 Genetic analysis of cytochrome P450 system | Q33251404 | ||
| Two mutant alleles of the human cytochrome P-450db1 gene (P450C2D1) associated with genetically deficient metabolism of debrisoquine and other drugs | Q33632924 | ||
| Characterization of the common genetic defect in humans deficient in debrisoquine metabolism | Q34049056 | ||
| Induction of microsomal enzymes by foreign chemicals and carcinogenesis by polycyclic aromatic hydrocarbons: G. H. A. Clowes Memorial Lecture. | Q34270623 | ||
| The human debrisoquine 4-hydroxylase (CYP2D) locus: sequence and identification of the polymorphic CYP2D6 gene, a related gene, and a pseudogene | Q35197475 | ||
| Metabolic factors in cancer susceptibility | Q37804084 | ||
| Lung cancer and the debrisoquine metabolic phenotype | Q41235407 | ||
| Genetic predisposition to bladder cancer: ability to hydroxylate debrisoquine and mephenytoin as risk factors | Q41463151 | ||
| Identification of the primary gene defect at the cytochrome P450 CYP2D locus | Q48250898 | ||
| Polymorphic oxidation of debrisoquine in women with breast cancer | Q57586085 | ||
| Lung cancer risk, occupational exposure, and the debrisoquine metabolic phenotype | Q58047534 | ||
| Metabolic oxidation phenotypes as markers for susceptibility to lung cancer | Q59082319 | ||
| Absence of hepatic cytochrome P450bufI causes genetically deficient debrisoquine oxidation in man | Q70219763 | ||
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 107-112 | |
| P577 | publication date | 1992-11-01 | |
| P1433 | published in | Environmental Health Perspectives | Q1345904 |
| P1476 | title | Molecular genetic analysis of the cytochrome P450-debrisoquine hydroxylase locus and association with cancer susceptibility | |
| P478 | volume | 98 |
| Q42133366 | A simplified assay for the arylamine N-acetyltransferase 2 polymorphism validated by phenotyping with isoniazid |
| Q34387297 | An analysis of phenotypic variation in the familial cancer syndrome von Hippel-Lindau disease: evidence for modifier effects |
| Q42982276 | Cytochrome P450 2D6 polymorphism is a molecular genetic marker of liver cirrhosis progression |
| Q38303763 | DNA haplotype-dependent differences in the amino acid sequence of debrisoquine 4-hydroxylase (CYP2D6): evidence for two major allozymes in extensive metabolisers |
| Q24679438 | Genes other than BRCA1 and BRCA2 involved in breast cancer susceptibility |
| Q36927094 | Heterogeneity of tumor-induced gene expression changes in the human metabolic network |
| Q38482554 | Heterogeneous expression and polymorphic genotype of glutathione S-transferases in human lung |
| Q37608402 | Preventive oncology in the postmenopausal woman. |
| Q63225023 | The cytochrome P450 2D6 (CYP2D6) gene polymorphism among breast and head and neck cancer patients |
| Q41570913 | The molecular epidemiology of lung cancer |
Search more.